Trial record 10 of 12 for:    allostim

An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02409524
Recruitment Status : Unknown
Verified July 2016 by Immunovative Therapies, Ltd..
Recruitment status was:  Recruiting
First Posted : April 7, 2015
Last Update Posted : July 12, 2016
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2017
  Estimated Study Completion Date : August 2018